Cymabay Therapeutics Inc sell Midas
Start price
12.02.21
/
50%
€4.80
Target price
12.02.22
-
Performance (%)
-36.21%
End price
25.08.21
€3.06
Summary
This prediction ended on 25.08.21 with a price of €3.06. Midas correctly predicted massive losses of -36.21% for Cymabay Therapeutics Inc. Midas has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cymabay Therapeutics Inc | - | - | - | - |
| iShares Core DAX® | -0.100% | 3.931% | 32.407% | 80.117% |
| iShares Nasdaq 100 | 1.827% | 5.670% | 10.821% | 64.325% |
| iShares Nikkei 225® | -0.370% | 0.109% | -1.143% | 17.319% |
| iShares S&P 500 | 1.185% | 4.668% | 8.117% | 44.476% |
Comments by Midas for this prediction
In the thread Cymabay Therapeutics Inc diskutieren
Sell Cymabay Therapeutics Inc